glp-1 therapy for diabetes The Benefits of Therapy: Beyond Weight Loss Experts Encourage Use of GLP-1s

10.1038/s41598-025-01287-6 Sci Rep

59, converted by law n

Semaglutide | Drugs BNF (NICE)

10.1038/nrm1985 13 BridgemanS.EllisonG.NewsholmeP.MamotteC.KarpinskiP.SasiadekM

Research Into Transdermal GLP-1 Delivery Systems While no GLP-1 patches are currently available or authorised for patient use, research into transdermal delivery systems for peptide-based medications is an active area of pharmaceutical development

Novo Nordisk previously claimed to have been alarmed by "reports of medical spas, weight loss clinics, pharmacies, and other companies" selling compounded semaglutide to patients on the grounds that they "do not have the same safety, quality, and effectiveness assurances as Novo Nordisk's FDA-approved drugs." Compounding pharmacies are mostly regulated at the state level by boards of pharmacy